The LIN28/let-7 Pathway in Cancer

Overview

Journal Front Genet

Date 2017 Apr 13

PMID 28400788

Citations 258

Authors

Julien Balzeau

Miriam R Menezes

Siyu Cao

John P Hagan

Affiliations

Soon will be listed here.

Abstract

Among all tumor suppressor microRNAs, reduced let-7 expression occurs most frequently in cancer and typically correlates with poor prognosis. Activation of either LIN28A or LIN28B, two highly related RNA binding proteins (RBPs) and proto-oncogenes, is responsible for the global post-transcriptional downregulation of the let-7 microRNA family observed in many cancers. Specifically, LIN28A binds the terminal loop of precursor let-7 and recruits the Terminal Uridylyl Transferase (TUTase) ZCCHC11 that polyuridylates pre-let-7, thereby blocking microRNA biogenesis and tumor suppressor function. For LIN28B, the precise mechanism responsible for let-7 inhibition remains controversial. Functionally, the decrease in let-7 microRNAs leads to overexpression of their oncogenic targets such as MYC, RAS, HMGA2, BLIMP1, among others. Furthermore, mouse models demonstrate that ectopic LIN28 expression is sufficient to drive and/or accelerate tumorigenesis via a let-7 dependent mechanism. In this review, the LIN28/let-7 pathway is discussed, emphasizing its role in tumorigenesis, cancer stem cell biology, metabolomics, metastasis, and resistance to ionizing radiation and several chemotherapies. Also, emerging evidence will be presented suggesting that molecular targeting of this pathway may provide therapeutic benefit in cancer.

Citing Articles

Extracellular Microvesicle MicroRNAs and Imaging Metrics Improve the Detection of Aggressive Prostate Cancer: A Pilot Study.

Avasthi K, Choi J, Glushko T, Manley B, Yu A, Park J Cancers (Basel). 2025; 17(5).

PMID: 40075682 PMC: 11898942. DOI: 10.3390/cancers17050835.

Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy.

Schramm J, Sholler C, Menachery L, Vazquez L, Saulnier Sholler G J Clin Med. 2025; 14(4).

PMID: 40004600 PMC: 11856405. DOI: 10.3390/jcm14041068.

Fluorescence-based detection of Let-7a miRNA through HCR-based approach upon the in situ interaction of AuNPs@CdS QDs and FRET mechanism.

Hosseini F, Dadmehr M, Hosseini M Mikrochim Acta. 2025; 192(3):153.

PMID: 39937314 DOI: 10.1007/s00604-025-07018-y.

Transcriptomic and Functional Landscape of Adult Human Spinal Cord NSPCs Compared to iPSC-Derived Neural Progenitor Cells.

Jagadeesan S, Galuta A, Sandarage R, Tsai E Cells. 2025; 14(2).

PMID: 39851491 PMC: 11763936. DOI: 10.3390/cells14020064.

Expression of miR-15b-5p and toll-like receptor4 as potential novel diagnostic biomarkers for hepatitis C virus-induced hepatocellular carcinoma.

Mohamed A, Nagah Amer N, Osama N, Hafez W, Abdelrahman Ali A, Shaheen M Noncoding RNA Res. 2025; 10():262-268.

PMID: 39844891 PMC: 11751402. DOI: 10.1016/j.ncrna.2024.12.003.

References

Yang J, Bennett B, Luo S, Inoue K, Grimm S, Schroth G . LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells. Mol Cell Biol. 2015; 35(18):3225-43. PMC: 4539381. DOI: 10.1128/MCB.00426-15. View

Li Y, VandenBoom 2nd T, Kong D, Wang Z, Ali S, Philip P . Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009; 69(16):6704-12. PMC: 2727571. DOI: 10.1158/0008-5472.CAN-09-1298. View

Hu Q, Peng J, Liu W, He X, Cui L, Chen X . Lin28B is a novel prognostic marker in gastric adenocarcinoma. Int J Clin Exp Pathol. 2014; 7(8):5083-92. PMC: 4152071. View

Hamada S, Masamune A, Takikawa T, Suzuki N, Kikuta K, Hirota M . Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochem Biophys Res Commun. 2012; 421(2):349-54. DOI: 10.1016/j.bbrc.2012.04.014. View

Degrauwe N, Schlumpf T, Janiszewska M, Martin P, Cauderay A, Provero P . The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing. Cell Rep. 2016; 15(8):1634-47. DOI: 10.1016/j.celrep.2016.04.086. View

Esquela-Kerscher A, Trang P, Wiggins J, Patrawala L, Cheng A, Ford L . The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle. 2008; 7(6):759-64. DOI: 10.4161/cc.7.6.5834. View

Wilbert M, Huelga S, Kapeli K, Stark T, Liang T, Chen S . LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol Cell. 2012; 48(2):195-206. PMC: 3483422. DOI: 10.1016/j.molcel.2012.08.004. View

Oh J, Kim J, Byun J, Kim I . Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys. 2009; 76(1):5-8. DOI: 10.1016/j.ijrobp.2009.08.028. View

Picard D, Miller S, Hawkins C, Bouffet E, Rogers H, Chan T . Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol. 2012; 13(8):838-48. PMC: 3615440. DOI: 10.1016/S1470-2045(12)70257-7. View

10.

Cao D, Liu A, Wang F, Allan R, Mei K, Peng Y . RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases. Mod Pathol. 2010; 24(2):288-96. DOI: 10.1038/modpathol.2010.195. View

11.

Hanna J, Saha K, Pando B, van Zon J, Lengner C, Creyghton M . Direct cell reprogramming is a stochastic process amenable to acceleration. Nature. 2009; 462(7273):595-601. PMC: 2789972. DOI: 10.1038/nature08592. View

12.

Viswanathan S, Daley G . Lin28: A microRNA regulator with a macro role. Cell. 2010; 140(4):445-9. DOI: 10.1016/j.cell.2010.02.007. View

13.

Viswanathan S, Daley G, Gregory R . Selective blockade of microRNA processing by Lin28. Science. 2008; 320(5872):97-100. PMC: 3368499. DOI: 10.1126/science.1154040. View

14.

Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl E, Nitsch R . A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol. 2008; 10(8):987-93. DOI: 10.1038/ncb1759. View

15.

OConnor M, Xiang D, Shigdar S, Macdonald J, Li Y, Wang T . Cancer stem cells: A contentious hypothesis now moving forward. Cancer Lett. 2013; 344(2):180-7. DOI: 10.1016/j.canlet.2013.11.012. View

16.

Zhang J, Ratanasirintrawoot S, Chandrasekaran S, Wu Z, Ficarro S, Yu C . LIN28 Regulates Stem Cell Metabolism and Conversion to Primed Pluripotency. Cell Stem Cell. 2016; 19(1):66-80. DOI: 10.1016/j.stem.2016.05.009. View

17.

Xu B, Zhang K, Huang Y . Lin28 modulates cell growth and associates with a subset of cell cycle regulator mRNAs in mouse embryonic stem cells. RNA. 2009; 15(3):357-61. PMC: 2657009. DOI: 10.1261/rna.1368009. View

18.

Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M . CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol. 2014; 128(2):291-303. PMC: 4159569. DOI: 10.1007/s00401-014-1291-1. View

19.

Qiu J, Huang P, You J, Zou R, Wang L, Hong J . LIN28 expression and prognostic value in hepatocellular carcinoma patients who meet the Milan criteria and undergo hepatectomy. Chin J Cancer. 2012; 31(5):223-32. PMC: 3777525. DOI: 10.5732/cjc.011.10426. View

20.

Roos M, Pradere U, Ngondo R, Behera A, Allegrini S, Civenni G . A Small-Molecule Inhibitor of Lin28. ACS Chem Biol. 2016; 11(10):2773-2781. DOI: 10.1021/acschembio.6b00232. View